Gene Therapy Achieves Early Success Against Hereditary Bleeding Disorder A study on gene therapy offers first proof that adults with hemophilia B benefit from treatment, reducing need for injections with clotting factor to prevent bleeds. [Press release from University College London discussing online prepublication in The New England Journal of Medicine] Press Release | Abstract
Biodegradable Poly(Amine-Co-Ester) Terpolymers for Targeted Gene Delivery Here investigators describe the synthesis of a series of high molecular weight terpolymers with low charge density, and show that they exhibit efficient gene delivery, some surpassing the efficiency of the commercial transfection reagents Polyethylenimine and Lipofectamine 2000. [Nat Mater] Abstract | Press Release
Study Points to Novel Way to Improve Outcomes from Umbilical Cord Blood Transplants A new method to boost the number of immune cells in umbilical cord blood prior to cord blood transplants for cancer patients appears to lead to a quicker rebuilding of a new immune system in the patient’s body than with a conventional cord blood transplant procedure, according to new research. [Press release from the Perelman School of Medicine at the University of Pennsylvania discussing research presented at the 53rd Annual Meeting of the American Society of Hematology, San Diego] Press Release
Update on TK Clinical Benefit Presented at ASH and Expansion of Phase III Trial in Europe MolMed S.p.A. presented an update on the clinical benefit following treatment with its investigational cell-based therapy TK for high-risk leukemias in adult patients: patients treated, including the first patients enrolled in the ongoing Phase III trial (TK008), show restoration of a fully functional immune system. [Press release from MolMed S.p.A. discussing research presented at the 53rd Annual Meeting of the American Society of Hematology (ASH), San Diego] Press Release
Researchers Use Stem Cells to Gain New Insight into Severe Childhood Form of Epilepsy A team of researchers investigating the fundamental cause of Dravet syndrome have reprogrammed fibroblasts from Dravet patients and generated patient-specific neurons – which could help determine new therapies or better medications for the syndrome. [Press release from the University of Michigan Health System discussing research presented at the American Epilepsy Society’s 65th Annual Meeting, Baltimore] Press Release
New Chief for HHS’s Research Misconduct Office The federal office that guards against scientific misdeeds in biomedical research has a new director. David E. Wright will take the helm of the Department of Health and Human Services (HHS) Office of Research Integrity in January. [Department of Health and Human Services, United States] Press Release
UK Cancer Charity Slashes Research Budget One of Britain’s largest biomedical funders, Cancer Research UK, will slash research spending because of falling donations, the charity announced. [Cancer Research UK, United Kingdom] Press Release
German Science Organizations Slam European Court Over Stem-Cell Ruling The powerful Alliance of German Scientific Organizations has now publicly criticized a ruling from the European Court of Justice that bans patenting of inventions involving human embryonic stem (ES) cells and says that research using human ES cell lines is immoral. [Alliance of German Scientific Organizations, Germany] Press Release
Stem Cell Research Milestone Stem cell scientists announced that they have submitted to the UK Stem Cell Bank their first clinical grade human embryonic stem cell lines that are free from animal-derived products. [King’s College London] Press Release
£50 Million Technology and Innovation Centre in Cell Therapy to Come to London The Technology Strategy Board has announced further details about its Technology and Innovation Centre in Cell Therapy. The new centre will support the development and commercialization of cell therapies and advanced therapeutics, as well as the underpinning technologies for manufacturing, quality control, safety and efficiency. [Technology Strategy Board] Press Release
Collaboration Aimed at Automating Manufacturing of Regenerative Medicine Therapies Wake Forest Baptist Medical Center’s Institute for Regenerative Medicine is teaming up with North Carolina State University’s Edward P. Fitts Department of Industrial and Systems Engineering with the goal of applying the latest advances in industrial engineering to the new field of regenerative medicine. [Wake Forest Baptist Medical Center] Press Release
Government to Improve Regulation of Therapeutic Goods The Australian government will introduce a comprehensive package of reforms for Australia’s Therapeutic Goods Administration to ensure the regulation of medicines and medical devices is more effective and transparent. Press Release